Market Place
Sourcing Support
AstraZeneca unveils data behind Phase III-bound oral GLP-1
08 Jun 2026 //
PRESS RELEASE
Ampligen Plus Imfinzi Shows Promise Result in Pancreatic Cancer
08 Jun 2026 //
GLOBENEWSWIRE
Ultomiris Cuts Proteinuria 43.4% vs Placebo in IgAN Ph III Trial
07 Jun 2026 //
PRESS RELEASE
AstraZeneca Marks Largest-Ever Share Transfer in NYSE History
05 Jun 2026 //
PR NEWSWIRE
Leica Biosystems Expands Collaboration on AI-Powered Diagnostics
03 Jun 2026 //
PRESS RELEASE
Camizestrant Combo Cuts Risk by 55% in ESR1+ Breast Cancer
02 Jun 2026 //
BUSINESSWIRE
Astrazeneca`s Triplet Combo Succeeds In Liver Cancer Subgroup
01 Jun 2026 //
FIERCE PHARMA
AIM Completes DURIPANC Phase 2 Enrollment Ahead of Schedule
01 Jun 2026 //
GLOBENEWSWIRE
AstraZeneca India FY26 Revenue Climbs 33% to Rs 22.76B
01 Jun 2026 //
INDPHARMAPOST
TYK Medicine Posts Brain Mets Data for Tagrisso Challenger
30 May 2026 //
FIRSTWORD PHARMA
Anselamimab Fails in LC Amyloidosis; Kappa Signal Persists
29 May 2026 //
PRESS RELEASE
Nucs AI Collaborates on Radioconjugate Response Prediction
29 May 2026 //
PR NEWSWIRE
AstraZeneca Gains 2nd Bladder Cancer Nod for Imfinzi
28 May 2026 //
FIERCE PHARMA
FDA Delays Ruling on AstraZeneca Breast Cancer Drug
27 May 2026 //
FIERCE PHARMA
CDT Announces Canadian Patent For AZD5904 In Male Infertility
27 May 2026 //
GLOBENEWSWIRE
CHMP Backs Enhertu for Previously Treated HER2+ Solid Tumors
22 May 2026 //
BUSINESSWIRE
Datroway Approved as 1st ADC for 1L Triple-Negative Breast Cancer
22 May 2026 //
BUSINESSWIRE
CHMP Backs AZ`s Breast Cancer Drug After FDA Adcomm Rejection
22 May 2026 //
FIERCE PHARMA
AstraZeneca to Share Phase 3 Cancer Data at ASCO 2026
22 May 2026 //
PRESS RELEASE
AstraZeneca Wins EU Backing for Breast Cancer Drug
22 May 2026 //
ENDPOINTS
AstraZeneca wins Nod for Blood Pressure Pill
18 May 2026 //
BIOSPACE
Astrazeneca Pharms’ Baxfendy Receives Approval in US
15 May 2026 //
FDA
Enhertu Adds Two More Breast Cancer Indications To Its US Label
15 May 2026 //
FDA
Astrazeneca Follows Merck With Phase 3 Win In Bladder Cancer
15 May 2026 //
ENDPOINTS
VOLGA Trial: Imfinzi Plus EV Boosts Survival in Bladder Cancer
14 May 2026 //
BUSINESSWIRE
Astrazeneca Follows Merck With Phase 3 Win In Bladder Cancer
14 May 2026 //
ENDPOINTS
Owkin to Build AI Agents Under Multi-Year AstraZeneca Agreement
13 May 2026 //
BUSINESSWIRE
Astrazeneca Initiates K+ Connect To Enhance Hyperkalemia
13 May 2026 //
INDPHARMAPOST
AstraZeneca Licenses Owkin AI Scientist Platform
13 May 2026 //
CONTRACTPHARMA
Onco-Innovations Initiates Research Collaboration In Promai Study
12 May 2026 //
ACCESSWIRE
Immunai and AstraZeneca Expand AI-Driven Biomarker Project
08 May 2026 //
AI JOURNAL
CDT Advances AZD5904 to Global Patent Phase
06 May 2026 //
GLOBENEWSWIRE
Astrazeneca Breast Cancer Drug Fails FDA Advisory Committee
01 May 2026 //
BIOSPACE
FDA AdCom Backs Capivasertib for PTEN-Deficient mHSPC
30 Apr 2026 //
BUSINESSWIRE
FDA Panel Rejects AstraZeneca Oral SERD Over Insufficient OS Data
30 Apr 2026 //
FIRSTWORD PHARMA
AstraZeneca Cuts Asthma and Rare Disease Units; Boosts Cancer
30 Apr 2026 //
BIOSPACE
AstraZeneca Faces Uphill Adcomm Battle Amid FDA Questions
29 Apr 2026 //
BIOSPACE
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
AstraZeneca Reports Q1 2026 Financial Results
29 Apr 2026 //
BUSINESSWIRE
AstraZeneca Pledges £300M UK Expansion Boost
29 Apr 2026 //
ENDPOINTS NEWS
FDA, AstraZeneca prep for oncology adcomm
29 Apr 2026 //
ENDPOINTS
BREZTRI Approved as First Triple Asthma Therapy in U.S.
28 Apr 2026 //
BUSINESSWIRE
Astrazeneca, Amgen To Pilot FDA`s Real-Time Trial Model
28 Apr 2026 //
FIRSTWORD PHARMA
SAPHNELO Gets U.S. Nod as Self-Injection Autoinjector for SLE
27 Apr 2026 //
BUSINESSWIRE
Astrazeneca’s Biologics Saphnelo Receives Approval in US
24 Apr 2026 //
FDA
Astrazeneca`s Il-33 Biologic Shows Benefits In COPD In Third
22 Apr 2026 //
PHARMIWEB
Astra eyes 5th Ultomiris indication after kidney disease trial
22 Apr 2026 //
PRESS RELEASE
Tozorakimab Meets Primary Endpoint In Phase 3 MIRANDA Trial
21 Apr 2026 //
PHARMIWEB
Carvykti Shows Promise Early in Myeloma; AstraZeneca Wins
21 Apr 2026 //
ENDPOINTS
AstraZeneca Backs India Coronary Conquest 2026 Program
21 Apr 2026 //
INDPHARMAPOST
Astra`s Tozorakimab Delivers Reduction in Lung Disease Flare-ups
20 Apr 2026 //
REUTERS
Astrazeneca`s IL-33 To Broaden Biologics Reach In COPD
16 Apr 2026 //
FIRSTWORD PHARMA
FDA signs off on generics for AstraZeneca`s Farxiga
13 Apr 2026 //
FDA
U.S. FDA Approves Generic Dapagliflozin for India
09 Apr 2026 //
INDPHARMAPOST
AstraZeneca, Roche-backed study supports risk-based HF screening
06 Apr 2026 //
INDPHARMAPOST
IMFINZI + IMJUDO Improves PFS in Early Liver Cancer
02 Apr 2026 //
BUSINESSWIRE
Another Astrazeneca Emerald Glimmers In Liver Cancer
02 Apr 2026 //
FIERCE PHARMA
AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal
31 Mar 2026 //
FIERCE BIOTECH
Astrazeneca In Vivo Data Shows Potential, Despite Patient Death
28 Mar 2026 //
FIERCE BIOTECH
AstraZeneca`s COPD Hit Revives Class Rocked by Flops
27 Mar 2026 //
FIERCE BIOTECH
